Brief Communication | Published:

Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation

Nature Genetics volume 42, pages 10491051 (2010) | Download Citation

Abstract

We used resequencing and genotyping in African Americans with sickle cell anemia (SCA) to characterize associations with fetal hemoglobin (HbF) levels at the BCL11A, HBS1L-MYB and β-globin loci. Fine-mapping of HbF association signals at these loci confirmed seven SNPs with independent effects and increased the explained heritable variation in HbF levels from 38.6% to 49.5%. We also identified rare missense variants that causally implicate MYB in HbF production.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Proc. Natl. Acad. Sci. USA 104, 11346–11351 (2007).

  2. 2.

    et al. Nat. Genet. 39, 1197–1199 (2007).

  3. 3.

    et al. Proc. Natl. Acad. Sci. USA 105, 1620–1625 (2008).

  4. 4.

    et al. Proc. Natl. Acad. Sci. USA 105, 11869–11874 (2008).

  5. 5.

    et al. Science 322, 1839–1842 (2008).

  6. 6.

    et al. Nature 460, 1093–1097 (2009).

  7. 7.

    et al. Nature 461, 747–753 (2009).

  8. 8.

    , , , & Science 324, 387–389 (2009).

  9. 9.

    , , , & PLoS Biol. 8, e1000294 (2010).

  10. 10.

    et al. Sickle Cell Disease: Basic Principles and Clinical Practice (Lippincott Williams & Wilkins, Philadelphia, Pennsylvania, USA1994).

  11. 11.

    et al. Proc. Natl. Acad. Sci. USA 82, 2111–2114 (1985).

  12. 12.

    et al. Blood 115, 1815–1822 (2010).

  13. 13.

    et al. Blood 114, 3935–3937 (2009).

  14. 14.

    et al. Hum. Genet. 127, 303–314 (2009).

  15. 15.

    et al. PLoS Genet. 2, e132 (2006).

Download references

Acknowledgements

We thank all the individuals who participated in this study, and T. Nguyen and M. Beaudoin for DNA genotyping support. We thank S. Raychaudhuri for critical reading of the manuscript, G. Boucher for statistical advice and the CARe Sickle Cell Disease working group for providing the Cooperative Study of Sickle Cell Disease (CSSCD) principal components. This work was funded by the Fondation de l'Institut de Cardiologie de Montréal (to G.L.) and was supported by an Innovations in Clinical Research Award grant from the Doris Duke Charitable Foundation (to G.L. and J.N.H.). Resequencing services were provided by the University of Washington, Department of Genome Sciences, under US Federal Government contract number N01-HV-48194 from the National Heart, Lung, and Blood Institute.

Author information

Affiliations

  1. Montreal Heart Institute, Montréal, Québec, Canada.

    • Geneviève Galarneau
    •  & Guillaume Lettre
  2. Divisions of Genetics and Endocrinology and Program in Genomics, Children's Hospital Boston, Boston, Massachusetts, USA.

    • Cameron D Palmer
    •  & Joel N Hirschhorn
  3. Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, USA.

    • Cameron D Palmer
    •  & Joel N Hirschhorn
  4. Division of Hematology and Oncology, Children's Hospital Boston, Boston, Massachusetts, USA.

    • Vijay G Sankaran
    •  & Stuart H Orkin
  5. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

    • Vijay G Sankaran
    •  & Stuart H Orkin
  6. Howard Hughes Medical Institute, Boston, Massachusetts, USA.

    • Stuart H Orkin
  7. Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.

    • Joel N Hirschhorn
  8. Départment de Médecine, Université de Montréal, Montréal, Québec, Canada.

    • Guillaume Lettre

Authors

  1. Search for Geneviève Galarneau in:

  2. Search for Cameron D Palmer in:

  3. Search for Vijay G Sankaran in:

  4. Search for Stuart H Orkin in:

  5. Search for Joel N Hirschhorn in:

  6. Search for Guillaume Lettre in:

Contributions

V.G.S., S.H.O., J.N.H. and G.L. conceived and designed the experiment. G.G., C.D.P. and G.L. performed the experiments. G.G., C.D.P. and G.L. analyzed the data. G.G., C.D.P., V.G.S., S.H.O., J.N.H. and G.L. contributed reagents, materials and/or analysis tools. G.G. and G.L. wrote the paper with contributions from all authors.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Guillaume Lettre.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Tables 1–10 and Supplementary Figures 1 and 2

Excel files

  1. 1.

    Supplementary Table 2

    DNA sequence variants identified at the BCL11A, HBS1L-MYB and A-globin loci by DNA re-sequencing in the HapMap Northern European (CEU) and West African (YRI) founders, and in 70 sickle cell anemia (SCA) patients from the Cooperative Study of Sickle Cell Disease (CSSCD)

  2. 2.

    Supplementary Table 3

    Association results with HbF levels for all 95 common SNPs (minor allele frequency A1%) genotyped in 1,032 African-American sickle cell anemia (SCA) patients from the Cooperative Study of Sickle Cell Disease (CSSCD)

  3. 3.

    Supplementary Table 6

    Association results to fetal hemoglobin (HbF) levels for imputed SNPs

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/ng.707

Further reading